Chromosomal fusions of the N-terminal region of the Ewings Sarcoma Oncogene (EWS-Activation-Domain, EAD) to the DNA-binding domains of a variety of cellular transcription factors, produce oncogenic proteins (EWS-fusion proteins (EFPs)) that cause a variety of malignancies. The EAD can act as a potent transcriptional activation domain and is required for the oncogenic activity of EFPs. Previous studies demonstrating a physical interaction between the EAD and the human RNA Polymerase II subunit hsRPB7 suggest a crucial role for RPB7 and its partner, RPB4, in EAD function. Homologues of hsRPB4/7 exist in S. cerevisiae, and here we describe an RPB4/7-dependent yeast assay for EAD-mediated trans-activation. Conditional yeast strains lacking RPB4 are defective for transactivation by a Gal4/EAD fusion protein at the permissive temperature. Introduction of hsRPB4 alone is unable to rescue trans-activation, while a combination of hsRPB4 and hsRPB7 signi®cantly rescues activity. These ®ndings provide the ®rst functional evidence for a direct role of the RPB4/7 complex in EAD-mediated trans-activation. In addition, the yeast assay provides a tractable system for further molecular analysis of EAD and RPB4/7 action. Oncogene (2001) 20, 1519 ± 1524.
Chromosomal fusion of the N-terminal region of the Ewings Sarcoma Oncogene (EWS) to the DNAbinding domains of a variety of cellular transcription factors gives rise to dominant oncogenes (EWS Fusion Proteins, EFPs, Figure 2a ) that cause distinct sarcomas (May and Denny, 1997; Rauscher, 1997; Ron, 1997) . EFPs are potent transcriptional activators dependent on an activation domain (EWS-Activation-Domain, EAD, Figure 2a ) from EWS. The spectrum of malignancies associated with EFPs are thought to arise via EFP-induced transcriptional de-regulation, with the tumor phenotype speci®ed by the EWS fusion partner and cell type. Agents that antagonize EFPs can also inhibit cellular proliferation (reviewed by Kovar et al., 1999) , indicating that EFPs are potential therapeutic targets.
Extensive mutational analysis of the EAD has been performed in mammalian cells (Ohno et al., 1993; Prasad et al., 1994; Sanchez-Garcia and Rabbitts, 1994; Brown et al., 1995; Lessnick et al., 1995; Fujimura et al., 1996; Pan et al., 1998; Kim et al., 1998) . In addition, the EAD can activate transcription in yeast (S. cerevisiae) when fused to the Gal4 DNA-binding domain (Pan et al., 1998) . Despite much eort however, the mechanism of EAD action remains quite poorly characterized. This is largely due to the highly repetitive primary structure of the EAD, which has made it dicult to de®ne critical structure/function relationships. Pertinent to the study described here, the EAD binds directly to the human RNA polymerase II (Pol II) subunit hsRPB7, while the normal (nononcogenic) EWS protein is unable to do so (Bertolotti et al., 1998; Petermann et al., 1998) . Over-expression of hsRPB7 in mammalian cells can weakly stimulate EAD-mediated trans-activation (Petermann et al., 1998) and the ability of hsRPB7 to bind to the EAD but not intact EWS, correlates with trans-activation (Li and Lee, 2000) . Thus the above ®ndings suggest that hsRPB7 is involved in EAD-mediated trans-activation. With respect to the normal function of RPB7, studies in yeast show that yRPB7 functions in a sub-complex with another Pol II subunit yRPB4 (Edwards et al., 1991; Asturias et al., 1997; Jensen et al., 1998) and that RPB4 and RPB7 are both required for growth/survival under stress conditions (Woychik and Young, 1989) . yRPB7 and yRPB4 have structural homologues ( Figure  4a ) in Schizosaccharomyces pombe (Sakurai et al., 1999) , plants (Larkin and Guilfoyle, 1998) and humans (Khazak et al., 1995 , and a degree of functional homology as evidenced by the ability of hsRPB4/7 to partially complement yRPB4/7 (Khazak et al., 1995 .
Although they have highly related functions, yRPB7 is an essential gene in S. cerevisiae (Mckune et al., 1993) , while yRPB4 is conditional. yRPB4 deletion has only a minimal eect on growth (Woychik and Young, 1989) and global transcription (Choder and Young, 1993) at permissive temperatures. We therefore exploited the ability to assay the EAD in yeast and yRPB4 conditionality, to test whether EAD-mediated activation requires yRPB4. yRPB4 deletion strains (termed Y190Dr4) were generated from strain Y190 (Clonetech) and tested for temperature sensitive growth on agar plates (Figure 1a ) to verify their integrity. Y190Dr4 grows normally at 238C, while at 308C there is a clear growth defect and at 378C a severe defect. As expected, growth at higher temperatures is fully restored by plasmid-borne yRPB4, while hsRPB4, or a combination of hsRPB4 and hsRPB7, has less capacity to rescue growth at 308C and is unable to rescue at 378C (Figure 1a ). Western blots of extracts from Y190Dr4 con®rm that yRPB4 and hsRPB4 are expressed at similar levels ( Figure 3b) . In liquid culture, Y190Dr4 grows slightly slower than Y190 at 238C and this eect was signi®cantly reduced by hsRPB4 (Figure 1b) . Thus under our experimental conditions, yRPB4 has little eect on growth at 238C, and at 308C (but not 378C), hsRPB4 or a combination of hsRBP4 and hsRPB7 (Figure 1a ) partially complement the growth defect to similar extents. These characteristics agree well with previous results (Woychik and Young, 1989) and authenticate the Y190Dr4 strain used in our experiments.
The EAD activates transcription in mammalian cells and yeast when fused to the DNA-binding domain of Gal4 (Lessnick et al., 1995; Kim et al., 1998; Pan et al., 1998) and Gal4/EAD fusions are therefore useful for studying EAD action independently of EWS fusion partners present in EFPs (Figure 2a) . We have previously shown that a protein (G4D287) containing the intact EAD (EWS residues 1 ± 287) fused to the Gal4 DNA-binding domain (aa1 ± 147) activates transcription of a chromosomal Gal4-dependent-b-galactosidase reporter in Y190 (Pan et al., 1998) . We examined the ability of Y190Dr4 to support transactivation by G4D287 at 238C (Figure 2b ). Transactivation by G4D287 was found to be highly defective in four independent isolates (two are shown, Dr4#2 and Dr4#16) giving LacZ activity close to background. Loss of trans-activation in Y190Dr4 is not due to reduced expression of G4D287 ( Figure 2b ). The above results strongly suggests that yRPB4 is important for trans-activation by the EAD in S. cerevisiae.
The genes for RPB4 and RPB7 are structurally (and to some extent functionally) conserved between S. cerevisiae and humans (Khazak et al., 1995 . However, protein ± protein interaction studies indicate that hsRPB4 is unable to directly associate with yRPB7 . Since RPB4 and RPB7 are thought to act in a concerted manner as a subcomplex, this prompted us to test the ability of hsRPB4 to functionally interact with yRPB7 and to rescue EAD-mediated trans-activation in Y190Dr4 (Figure 3 ). In contrast to yRPB4 as the positive control (82+9% rescue, Figure 3a ) hsRPB4 does not restore trans-activation in Y190Dr4 (1.5+0.3% rescue). yRPB4 and hsRPB4 are expressed at similar levels and G4D287 levels are not aected by hsRPB4 coexpression ( Figure 3b ). Thus, hsRPB4 is unable to cooperate with the yeast transcriptional machinery (including yRPB7) to support EAD-mediated transactivation. Strikingly however, a combination of hsRPB4 and hsRPB7 is able to support transactivation by G4D287 to a signi®cant extent (34+9% rescue) and introduction of hsRPB7 alone has only a minimal eect (2.7+0.2% rescue). The above results demonstrate that hsRPB4 and hsRPB7 can functionally cooperate in a highly speci®c manner to support trans-activation in yeast.
In contrast to the inability of hsRPB4 to bind to yRPB7 , hsRPB7 is able to interact weakly with yRPB4 and eciently associates with yeast Pol II including yRPB4 . hsRPB7 can also ful®ll the essential RPB7 function in S. cerevisiae (Khazak et al., 1995) . These Figure 1 Growth characteristics of Y190Dr4. (a) Wild type yeast (Y190) or the RPB4 deletion strain Y190Dr4 were grown in liquid culture and equal numbers of cells were spotted onto YPD plates and incubated at the temperatures shown to the left. Cells containing plasmids expressing yRPB4 or hsRPB4 plus hsRPB7 were grown in selective medium before plating on YPD. (b) For growth curves in liquid culture, cells were ®rst grown under appropriate selection for plasmids and then transferred to YPD for measurement of growth rates. The growth curves shown were performed at 238C and in the presence of G4D287. Gene deletion in Y190 (Clontech, genotype MATa, 112, gal4D, gal80D , cyh r 2, LYS2:: GAL1 UAS -HIS3 TATA -HIS3, URA3::GAL1 UAS -GAL1 TATA -LacZ) was achieved by a PCR-based method using a geneticin resistance gene (KanMK6) as marker (Wach, 1996) ®ndings suggested that hsRPB7 might be able to cooperate with yRPB4 in trans-activation. We tested this by constructing a yeast strain (Y190hsr7) lacking yRPB7 but maintained by hsRPB7 (Figure 3a) . Transactivation in Y190hsr7 is less than that observed in Y190 (as indicated by staining of ®lters for LacZ activity) but is only threefold less (34+3%) when quantitated from cells in log phase liquid cultures (Figure 3a ). Thus, hsRPB7 is able to cooperate to a signi®cant extent with yRPB4 in trans-activation. The following considerations are pertinent to interpretation of the above results. First, the experiments are performed under conditions (238C) in which there is no obvious growth defect (Figure 1 ) and only a small reduction in global transcription (Choder and Young, 1993) . Thus the role of RPB4 in cell growth and transactivation by the EAD are distinguishable. Second, trans-activation by G4D287 is strictly dependent on the EAD indicating that the eects of RPB4/7 do not re¯ect a general stimulation of basal transcription. Taken together therefore, our results provide direct functional evidence that both RPB4 and RPB7 are required for trans-activation by the EAD in S. cerevisiae.
If recruitment of RPB7 to the promoter is sucient (in the presence of RPB4) to activate transcription then arti®cial recruitment of RBP7 by fusion to the Gal4 DNA-binding domain should result in ecient activation, independently of the EAD. We tested this possibility (Figure 3c ) and found that in Y190, a Gal4hsRPB7 fusion protein (G4RPB7) gives a level of trans-activation that is comparable to that for the intact EAD. Trans-activation by G4RPB7 is dependent on fusion of the Gal4 and hsRPB7 proteins and is defective in Y190Dr4 (Figure 3c) . Thus under our assay conditions, recruitment of RPB7 to the promoter results in ecient trans-activation (compared with that achieved by the EAD) but trans-activation remains RPB4-dependent. These results suggest that recruitment of RPB7 to the promoter by the EAD is sucient (in the presence of RPB4) for trans-activation.
Previous studies of protein ± protein interactions between EFPs and RPB7 (Bertolotti et al., 1998; Petermann et al., 1998) and the normal function of RPB4 and RPB7 (Edwards et al., 1991; Asturias et al., 1997; Jensen et al., 1998) suggested a model for transactivation by the EAD (Figure 4b ). To date however, the observation that over-expression of hsRPB7 in Trans-activation by the EAD in yeast. Y190 and Y190Dr4 (two independent isolates, Dr4#2 and Dr4#16) were tested for the ability to support trans-activation by G4D287 or the Gal4 DNAbinding domain (G4DBD) alone. Trans-activation of a chromosomal lacZ reporter was scored by staining of ®lters for bgalactosidase and quantitation by liquid assay using ONPG. Representative ®lters are shown and experiments were performed at 238C. Expression of G4D287 was con®rmed by Western blotting (right) of epitope tagged proteins. Plasmids expressing Gal4/EAD fusions were all derived from pGBT9 (Clontech) and pG4vector (Pan et al., 1998) mammalian cells can weakly stimulate transcriptional activity of the EAD (Petermann et al., 1998) is the only functional evidence to support the above model. In contrast, the approach described herein enabled a critical test of the involvement of RPB4/7 in transactivation and the results establish a role for both RPB4 and RPB7.
Correlation between the ability of dierent interspecies combinations of RPB4/7 to form an RPB4/7 complex (Khazak et al., 1995 and the ability to support trans-activation by the EAD (results presented herein) strongly suggests that RPB4 and RPB7 play a concerted role, most likely as a complex, in EADmediated trans-activation. Using the yeast assay, it will be of interest to test RPB4 mutants or inter-species chimeras (based on the homologies shown in Figure  4a ) for the ability to support trans-activation. The Nterminal conserved region (CR1) of RPB4 is sucient for binding to homologous RPB7 but also contains species-speci®c determinants for RPB4/7 interaction Sakurai et al., 1999) . In contrast, the E.coli a homology and CR2 are not involved in interaction with RPB7 (Sakurai et al., 1999) , suggesting that these regions may determine interaction with other Pol II components. Exploitation of chimeric proteins should allow characterization of the key molecular contacts involved in trans-activation by the EAD.
In the model presented above, the EAD works via recruitment of RPB4/7 to the promoter thereby allowing an interaction between RPB4/7 and Poll II that does not occur (or that is inecient) in actively growing S. cerevisiae cells. How closely does the yeast assay re¯ect events in mammalian cells? Our results and those of others suggest that interaction of the EAD with hsRPB4/7 and formation of RPB4/7 complexes that support trans-activation, in both cases work quite eciently in yeast. First, hsRPB4 and hsRPB7 can interact well in yeast . Second, the EAD achieves the same level of trans-activation as a Gal4RPB7 fusion protein (Figure 3c ) indicating that the EAD eciently recruits the RPB4/7 complex to the promoter. Besides the above interactions it remains likely, however, that higher order interactions between Pol II subunits (Acker et al., 1997) are critical for trans-activation, and such interactions might be suboptimal for activation by the EAD. RPB4 has recently been shown to interact with several other Pol II subunits (Schaller et al., 1999) thus increasing the number of determinants that might in¯uence trans-activation by the EAD. In light of the above, it might be worthwhile Figure 3 Cooperation of hsRPB4 and hsRPB7. (a) Y190Dr4 and Y190hsr7 were tested for the ability to support trans-activation by G4D287 in the presence of dierent combinations of human (hs) and yeast (y) RPB4/7 sub-units at 238C. Trans-activation of a chromosomal lacZ reporter was scored by staining of ®lters for b-galactosidase and the graph shows quantitation of reporter activity from liquid cultures (+s.e.m.). Y190hsr7 is maintained by human RPB7 expressed from phRPB7. phRPB4 was obtained by inserting hsRPB4 into pGAD424 (Clontech). pDGADv was created by cutting pGAD424 with HindIII and replacing the GAL4 sequences with a multiple cloning site. pyRPB4 was obtained by inserting yRPB4 into pDGADv between the BamHI/XhoI sites. phRPB7 was obtained by inserting hRPB7 into pDGADv between the NdeI and XhoI sites. phRPB4/7 was obtained by inserting an Sph1 fragment from phRPB4 (containing the hRPB4 cDNA and ADH promoter) into the SphI site (position 5) of phRPB7. (b) Western blots of epitope-tagged proteins show the expression of dierent RPB subunits in the presence (left) and absence (right) of G4D287. The pattern of bands is complicated due to proteolysis of G4D287 and the intact polypeptides representing G4D287, yRPB7 and hsRPB7 are indicated (*). (c) hsRPB7 was tested for the ability to activate transcription when fused to Gal4. Transactivation by G4RPB7 was scored by staining of ®lters for b-galactosidase in Y190 or Y190Dr4 in the absence and presence of yRPB4 as indicated. The presence of control proteins containing only the Gal4 DNA-binding domain (G4DBD) or normal hsRPB7 is also indicated to construct yeast reporter strains harboring the minimal EAD (EAD residues 1 ± 82, that binds RPB7 (Petermann et al., 1998) but is inactive in yeast (Pan et al., 1998; Petermann et al., 1998) ), with a view to identifying or cloning stimulatory human components that might further optimize the yeast assay.
The EWS gene, together with the TLS/FUS and hTAFII68 genes, encode the TET family of RNA binding proteins. However, the EAD has mostly been studied in the context of oncogenic EFPs and the normal function of TETs in mammalian cells is not well understood. Moreover, it should be borne in mind that EAD-mediated trans-activation (even in mammalian cells) may simply re¯ect an adventitious property of EFPs (caused via interaction with RPB7) since the intact EWS protein does not bind to RPB7 (Bertolotti et al., 1998; Petermann et al., 1998) and does not activate transcription (Li and Lee, 2000) . To our knowledge, there are no TET/EAD homologues in S. cerevisiae and it may therefore be the case that EADmediated trans-activation has no precise physiological counterpart in this organism. Nonetheless, further studies of the EAD in S. cerevisiae should prove useful for understanding the normal mechanism of action of RPB4/7. RPB4/7 is able to stabilize pre-initiation complexes (Jensen et al., 1998) and it has been proposed that RPB4/7 acts during pre-initiation by converting Pol II from the open to closed conformation (Asturias et al., 1997) . Our results indicate that recruitment of RPB4/7 to the promoter (via the EAD) can stimulate transcription and therefore raise the possibility that RPB4/7 may be the direct target of certain yeast activators. This possibility is supported by the ®nding in mammalian cells that the retinoic acid receptor directly interacts with hsRPB7 (Shen et al., 1999) . It will be of signi®cance to identify yeast activators that directly contact RPB4/7 via a structural component unrelated to the EAD since such proteins might be involved in the RPB4/7 stress-response in S. cerevisiae.
The critical role of the EAD in both trans-activation and transformation by oncogenic EFPs is well Figure 4 (a) Protein sequence relationships between RPB4 and RPB7 from dierent species. Representations of RPB4 and RPB7 in Saccharomyces cerevisiae (s.c.), Schizosaccharomyces pombe (s.p.), Human (h.s.) and Arabidopsis (a.t.) are shown. For RPB4, two conserved regions (CR1 and CR2) are common to all three proteins but in s.c. a non-conserved region (which is homologous with the 70 kDa a-subunit of E. Coli RNA polymerase) separates CR1 and CR2. Per cent identities with the human sequence are shown. The region of hsRPB4 that is involved in binding to hsRPB7 is shown with a line. For RPB7 there is stronger overall homology than is the case for RPB4 and the RPB7 homology is dispersed evenly throughout the protein. Per cent identities with the human sequence are shown. (b) Mechanism of trans-activation by the EAD. For simplicity, only selected components in the transcription complex are shown. The EAD is bound to the promoter via the DNA-binding domain provided by the EFP (or Gal4 in our experiments) and the EAD directly contacts RPB7. Ecient trans-activation requires interaction of RPB7 with RPB4 and recruitment of the RPB4/7 sub-complex into active Pol II complexes. See text for discussion established. Moreover, the available evidence suggests that the EAD might represent an eective target for small molecule inhibitors that would, in turn, have potential as lead compounds for anti-cancer drugs. First, blocking EFP function can lead to reduced growth of tumor cells (reviewed by Kovar et al., 1999) . Second, interaction between the EAD and RPB7 is speci®c for EFPs (Bertolotti et al., 1998; Petermann et al., 1998) and blocking EAD/RPB7 interaction may therefore have a limited eect in normal cells. Third, the EAD has a highly repetitive primary structure based on an SYGQQS motif (May and Denny, 1997; Rauscher, 1997) that represents an attractive inhibitor target. Establishment of a yeast system that is humanized' with respect to EAD-mediated transactivation provides a manipulatable system for analysis of EAD action in living cells and should facilitate development of a faithful high-throughput screen for EAD inhibitors.
